Senior Director - HCP Marketing

USA (Remote)

$220K/yr – $255K/yrSenior Level10+ years expFull time

Posted 2 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the HCP brand strategy and execution for the US launch, drive segmentation and go-to-market plans, and lead compliant promotional campaigns end-to-end.

  • Translate market insights into go-to-market plans
  • Coordinate with medical, market access, and sales teams

Job Description

Responsibilities

  • Own HCP brand strategy, positioning, and messaging for the US launch of our product
  • Build launch-readiness plans and materials that land the brand with retina specialists and their teams.
  • Define HCP segmentation and targeting to focus commercial effort where it matters most.
  • Translate market insight into go-to-market plans across channels.
  • Lead development of branded, compliant promotional campaigns and content.
  • Manage agencies and creative partners to deliver on time and on budget.
  • Align message and sequencing with medical, market access, and sales.
  • Steward promotional review (MLR) so materials meet regulatory and compliance standards.

Requirements

  • 10+ years in pharma / biotech marketing, including HCP brand and launch leadership.
  • Proven launch experience bringing a provider-administered or specialty product to market.
  • Command of segmentation, go-to-market, and promotional / MLR processes.

Preferred

  • Ophthalmology / retina or buy-and-bill specialty experience.
  • People-leadership and agency-management track record.
  • Note this is an individual contributor role that supports the Head of Commercial on all things brand, segmentation, and promotion.

Benefits

  • Competitive base salary and annual performance bonus
  • Generous PTO
  • Flexible work environment — remote work balanced with regular in-person collaboration
  • In-office time used for planning, workshops, and faster decisions
  • Medical, dental, and vision starting day one
  • 401(k) with company match
  • Paid parental leave
  • Travel support for team onsites, launches, and field work
Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc.

3.0 Glassdoor

Outlook Therapeutics is a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVATM (bevacizumab-vikg; bevacizumab gamma), for the treatment of retina diseases, including wet AMD. LYTENAVATM (bevacizumab gamma) is the first ophthalmic formulation of bevacizumab to receive European Commission and MHRA Marketing Authorization for the treatment of wet AMD. Outlook Therapeutics is working to initiate its commercial launch of LYTENAVATM (bevacizumab gamma) in the EU and the UK as a treatment for wet AMD, expected in the second quarter of calendar 2025. In the United States, ONS-5010/LYTENAVATM is investigational, and a BLA has been resubmitted to the FDA in the United States. If approved in the United States, ONS-5010/LYTENAVATM, would be the first approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet AMD.

Founded in 2011
Cranbury, New Jersey, USA
63 employees (2 in marketing)
40% recommend to a friend
83% CEO approval

Traffic Signals

Monthly Visitors
13.3K
Traffic Source Mix
Search
17.6%
Direct
75.6%
Social
5.1%

Headcount Trend

Current headcount: ~63

Marketing Team

Marketing Team Size
2 (3% of company)
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$381.7M
Last Raise
$5M
Post IPO Equity, 3 months ago

Funding History

  • Apr 2026
    Post IPO Equity • $5M
  • Mar 2026
    Post IPO Equity • $5M
  • Mar 2026
    Post IPO Debt • $18.4M

Recent News